# The National Health Service Commissioning Board (Additional Functions) Regulations 2017, Regulation 4: Power to conclude and manage framework agreements


(1) The Board may conclude and manage framework agreements to facilitate the purchase and supply of a service, drug, medicine or other substance or product to which paragraph (2) applies.
(2) This paragraph applies to a service, drug, medicine or other substance or product that is to be provided as part of the health service for—
(a) the purposes of preventing, diagnosing, monitoring or treating a physical or mental illness;
(b) the purposes of providing care to an individual; or
(c) a purpose related to any matter mentioned in sub-paragraph (a) or (b).
(3) In this regulation—
(a) “framework agreement” means an agreement between the Board and one (or more than one) economic operator (within the meaning of regulation 2 (definitions) of the Public Contracts Regulations 2015), the purpose of which is to establish the terms governing contracts to be entered into during a given period, in particular with regard to price and, where appropriate, the quantity envisaged; and
(b) “other substance or product” includes—
(i) medical supplies within the meaning of section 260(5) of the 2006 Act;
(ii) a medical device within the meaning of regulation 2 (interpretation) of the Medical Devices Regulations 2002; and
(iii) a human blood component.

---
Source: https://www.legislation.gov.uk/ukdsi/2017/9780111152928/regulation/4 (the official version)
Page: https://openlegislation.uk/draft-national-health-service-commissioning-board-additional-functions-regulations-2017/regulation-4
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.